Go to deals
Consumer & Retail

Obagi Cosmeceuticals has raised unitranche debt

Obagi Cosmeceuticals LLC has completed its recapitalization and growth financing. The financing facility was provided by the private credit group of TCW Asset Management Company LLC, a leading private credit lender with over US$5 billion of capital under management that specializes in providing senior-secured loans to US-based middle-market borrowers.

Headquartered in Long Beach, California, Obagi is a women-led independent global skincare company dedicated to providing advanced, clinically-proven skincare treatments for all skin types. The company provides more than 100 Obagi Medical® products to brighten, nourish, protect and enhance skin tone and texture through an extensive network of distributors, partners, physician offices and spas around the world, as well as its newly launched direct-to-consumer (DTC) platform. Obagi also offers dermatologist-tested, technologically advanced formulas through its Obagi Clinical™ line, accessible to consumers through Sephora.

Oaklins’ team in Los Angeles initiated this transaction, assisted in the negotiations and served as the financial advisor to Obagi Cosmeceuticals.

Service
Funding, debt advisory & ECM
Parties
“Oaklins’ team in Los Angeles did a phenomenal job managing the transaction process and negotiating a deal that sets Obagi up for success. Their team understood how to position our company’s massive opportunity to secure a financing structure that far exceeded our expectations.”

Jaime Castle

President and CEO, Obagi Cosmeceuticals LLC

Talk to the deal team

 Jonathan  Zucker

Jonathan Zucker

Managing Director

Los Angeles, United States
Oaklins Intrepid
 Kevin  Striepe

Kevin Striepe

Associate Director

Los Angeles, United States
Oaklins Intrepid
 Joseph  Wisniewski

Joseph Wisniewski

Associate

Los Angeles, United States
Oaklins Intrepid

Related deals

Frediani has been acquired by The Florence Group
Private Equity | Consumer & Retail

Frediani has been acquired by The Florence Group

The Frediani family have sold Frediani S.r.l. to The Florence Group.

Learn more
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Learn more
Laboratoires Phytogénèse has been acquired by Inostrale (Les Trois Chênes)
Consumer & Retail

Laboratoires Phytogénèse has been acquired by Inostrale (Les Trois Chênes)

The shareholders of Laboratoires Phytogénèse have sold the company to Inostrale (Les Trois Chênes).

Learn more